GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
 
Discovery Laboratories, Inc. (DSCO) [hlAlert]

Discovery Laboratories, Inc., formerly known as Ansan Pharmaceuticals, Inc., is a development-stage pharmaceutical company that focuses on developing compounds to treat respiratory diseases that affect the
ability of the lungs to absorb oxygen. It is initially developing its lead product candidate, Surfaxin, for use by newborn infants to treat two respiratory conditions in critical care units of hospitals. The second compound under development is SuperVent, which is intended to treat airway diseases such as cystic fibrosis (CF) and chronic bronchitis.
( Total: 7 Current Stock Recommendations )
Discovery Laboratories, Inc.   (7)
Sell 29% Buy 71%
Related companies
China Biologic ...   (4)
Buy 100%
BioSpecifics ...   (5)
Buy 100%
PROLOR Biotech, Inc.   (5)
Buy 100%
Opko Health Inc   (2)
Buy 100%
Flamel Technologies ...   (8)
Buy 100%
Aeterna Zentaris, ...   (12)
Buy 100%
Lannett Co Inc   (4)
Buy 100%
Anika Therapeutics ...   (4)
Buy 100%
Emergent ...   (6)
Buy 100%
Insys Therapeutics ...   (4)
Buy 100%
Filter by Gains:   
  
Rating:
Buy DSCO
down 79.42 %

Rating:
Buy DSCO
down 83.63 %

Rating:
Buy DSCO
down 86.31 %

Rating:
Buy DSCO
down 86.31 %
Discovery Laboratories, Inc. (DSCO) rated Buy by Lazard
Tuesday,  Aug 7, 2012  8:36 PM ET

Rating:
Sell DSCO
up 43.33 %

Rating:
Sell DSCO
up 52.77 %
Discovery Laboratories, Inc. (DSCO) rated Sell by Wedbush Morgan
Thursday,  Jul 2, 2009  9:25 AM ET

Rating:
Sell DSCO
up 52.77 %
Discovery Laboratories, Inc. (DSCO) rated Sell by Wedbush Morgan
Thursday,  Jul 2, 2009  9:37 AM ET

Rating:
Buy DSCO
down 83.85 %

Your Recent Stocks
SymbolLastChange
DSCO 3.77 up  947.22 %

RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy